Mitchell Sinkler & Starr’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,029
Closed -$142K 144
2023
Q1
$142K Hold
6,029
0.04% 139
2022
Q4
$168K Buy
+6,029
New +$154K 0.05% 138
2022
Q3
Sell
-6,601
Closed -$223K 113
2022
Q2
$223K Sell
6,601
-437
-6% -$15.3K 0.08% 110
2022
Q1
$246K Sell
7,038
-75
-1% -$2.56K 0.08% 110
2021
Q4
$217K Buy
+7,113
New +$232K 0.06% 117

Other funds holding OGN

Mitchell Sinkler & Starr's OGN Position: Q2 2023 in Review

Mitchell Sinkler & Starr sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 6,029 shares — an estimated $142K sold.

Mitchell Sinkler & Starr first reported a position in OGN in Q4 2021 and held it in 5 quarters. The position peaked at $246K in Q1 2022. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Mitchell Sinkler & Starr reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Mitchell Sinkler & Starr sold 6,029 Organon & Co shares in Q2 2023, an estimated $142K.
  • Mitchell Sinkler & Starr first reported a position in Organon & Co in Q4 2021 and held it in 5 quarters.
  • Mitchell Sinkler & Starr's Organon & Co position peaked at $246K in Q1 2022.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2023, filed 18 Jul 2023.